On April 30, 2020, the Food and Drug Administration (FDA) issued new guidance relaxing certain requirements under the Drug Supply Chain Security Act (DSCSA) for COVID-19 related drug products. In the guidance, FDA explained that under the DSCSA... Read More
As we reported here, attorneys representing state and local governments in the opioid litigation issued subpoenas to pharmacies that purchased narcotics from certain wholesalers and distributors. Notably concerning, the same attorneys are now... Read More
As New Jersey has become a hotspot in the COVID-19 outbreak, physicians and the public-at-large are looking for any remedies that may help alleviate symptoms or assist recovery. One hot topic has been the use of hydroxychloroquine. Originally an... Read More
https://youtu.be/72DTaqR4_yY Learn more about what Healthcare Providers and Pharmacies should know when it comes to downturns in business from COVID-19 in our latest video with Co-Founder Jonathan Levitt, Esq. and Partner Jesse Dresser,... Read More
Major retail pharmacy chains such as CVS and Walgreens have officially pointed the finger at physicians in the multi-district federal opioid litigation by filing third-party complaints against physicians earlier this year. The chains claim that the... Read More
Value Based Care is the future of the United States healthcare system and the Office of the Inspector General (OIG) for the US Department of Health and Human Services is in full agreement. The OIG recently issued a Notice of Proposed Rulemaking that... Read More
It is no secret that the opioid crisis has caused devastating impacts upon patients and their loved ones as well as the overall healthcare industry. Since the inception of the crisis, public Plan Sponsors including state agencies and municipalities,... Read More
Prime Therapeutics has announced that it will no longer accept Dispensing Physician entities into its pharmacy network starting January 29, 2018. The PBM will begin blocking PSAOs from adding physician dispensers. We also anticipate that Prime... Read More
A White Paper by Frier Levitt examines the ongoing practice by Pharmacy Benefit Managers (PBMs) to increase corporate profits through murky "Direct and Indirect Remuneration" fees—commonly known as "DIR Fees"—charged to community oncology... Read More
With the advent of value-based healthcare reimbursement becoming more of a reality each and every day for healthcare providers, physicians are frequently looking for new and innovative ways to maximize quality in the services they provide each of... Read More
